New portable handheld device delivers blood test results in an hour
HQ Team October 22, 2024: A new handheld device can isolate biomarkers for different diseases using sound waves from a single drop of
HQ Team October 22, 2024: A new handheld device can isolate biomarkers for different diseases using sound waves from a single drop of
HQ Team October 22, 2024: Hearing aids have emerged as a potentially significant factor in delaying the onset and progression of Parkinson’s disease
Danish pharmaceutical company, Novo Nordisk’s oral semaglutide drug to treat type 2 diabetes helped reduce heart diseases by 14% compared to a dummy
Malaria, which plagued the ancient pharaohs, has been eliminated in Egypt, according to a World Health Organization-certificate, — the third such in in
Astellas Pharma Inc.’s therapy to treat a form of gastric cancer got approval from the US drug regulator, according to a company statement.
Gilead Sciences, Inc. has withdrawn its bladder cancer drug from the US market and stopped its confirmatory clinical trial after it failed to
Merck & Co., Inc., and Gilead Sciences, Inc.’s investigational combinational drug for HIV treatment, put on clinical hold last year, has met a
HQ Team October 19, 2024: The U.S. Food and Drug Administration (FDA) has approved AbbVei’s drug Vyalev for the treatment of advanced Parkinson’s
HQ Team October 19, 2024: Stealth startup Treeline Biosciences has raised another $421 million, one of the biggest raises of the year in